SEC Form 4 · accession 0001209191-16-110105
ARADIGM CORP · ARDM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Juergen Kurt Froehlich
Officer — Chief Medical Officer
Period of report
Mar 18, 2016
Accepted (ET)
Mar 22, 2016 · 7:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013238
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 18, 2016 | A | 15,000 | $4.04 | A | 86,308 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3,F2 | $4.04 | Mar 18, 2016 | A | 13,000 | A | — | Mar 17, 2026 | Common Stock | 13,000 | 13,000 | D |
Explanation of responses
- F1Restricted stock award subject to repurchase by the Company, which repurchase right lapses quarterly over four years from March 18, 2016.
- F2Stock option vests in equal quarterly installments over four years, vesting start date of 3/18/2016.
- F3Inapplicable